BridgeBio Pharma, Inc. Common Stock (BBIO) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BBIO. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 461 institutions reported holding BBIO, with 193.3 million shares worth $14.4 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 16,948,997 | $1.3B | DECREASED |
| Janus Henderson (Jupiter Topco) | 14,110,278 | $1.1B | INCREASED |
| Kohlberg Kravis Roberts & Co. | 13,260,971 | $988M | UNCHANGED |
| Farallon Capital Management | 10,743,063 | $800M | INCREASED |
| BlackRock | 10,287,156 | $766M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Maricel Apuli (Chief Accounting Officer) | SELL | 2,000 | $146K | 2026-10-30 |
| Neil Kumar (Chief Executive Officer) | SELL | 1,279 | $89K | 2026-09-17 |
| Neil Kumar (Chief Executive Officer) | SELL | 8,721 | $602K | 2026-09-17 |
| Neil Kumar (Chief Executive Officer) | SELL | 100 | $9K | 2026-08-19 |
| Neil Kumar (Chief Executive Officer) | SELL | 1,800 | $152K | 2026-08-19 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Gilbert Cisneros (Democrat) | SALE | $1,001 - $15,000 | 2026-09-29 |
Full institutional holdings, insider history, and congressional trades for BridgeBio Pharma, Inc. Common Stock on SentiSense.